Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Gut|May 13, 2005
Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD studyP Malfertheiner, T Lind, S Willich, et al.
Gastroenterology|March 1, 1996
Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcerJ Labenz, B Tillenburg, U Peitz, et al.
Zeitschrift Fur Gastroenterologie|December 9, 2003
Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in GermanyA Madisch, K R Kulich, P Malfertheiner, et al.
Scandinavian Journal of Gastroenterology|August 1, 1997
Focal inflammatory infiltrations in gastric biopsy specimens are suggestive of Crohn's disease. Crohn's Disease Study Group, GermanyA Meining, E Bayerdörffer, E Bastlein, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosaS N Willich, M Nocon, M Kulig, et al.
Zeitschrift Fur Gastroenterologie|April 6, 1999
Prevalence and clinical importance of Helicobacter pylori infection in patients after partial gastric resection for peptic ulcer disease. A prospective evaluation of Helicobacter pylori infection on 50 resected patients compared with matched nonresected controlsD Schilling, H E Adamek, J Wilke, et al.
Digestive Diseases (Basel, Switzerland)|September 24, 2004
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa?M Vieth, U Peitz, J Labenz, et al.
European Journal of Gastroenterology & Hepatology|February 3, 2000
13C-octanoic acid breath test for gastric emptying measurementB Delbende, F Perri, O Couturier, et al.
Alimentary Pharmacology & Therapeutics|June 19, 2008
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control studyK Monkemuller, H Neumann, M Nocon, et al.
Alimentary Pharmacology & Therapeutics|March 18, 2005
A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO studyJ Labenz, D Armstrong, K Lauritsen, et al.
Pageof 16